Xu Y - Search Results

1

Prognostic Value of Combination of Lymphocyte-to-Monocyte-Ratio and CYFRA 21-1 in Esophageal Squamous Cell Carcinoma.

Yang Y, Liu Z, Jiang C, Pan J, Yu B, Zhu K, Xu Y, Li Z. Yang Y, et al. Among authors: xu y. World J Surg. 2023 Dec;47(12):3240-3249. doi: 10.1007/s00268-023-07190-3. Epub 2023 Oct 4. World J Surg. 2023. PMID: 37792039

2

Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.

Shen L, Niu X, Jian H, Xu Y, Yu Y, Lu S. Shen L, et al. Among authors: xu y. Lung Cancer. 2017 Sep;111:43-50. doi: 10.1016/j.lungcan.2017.07.001. Epub 2017 Jul 4. Lung Cancer. 2017. PMID: 28838396

3

Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.

Zhang X, Xu Y, He C, Guo X, Zhang J, He C, Zhang L, Kong M, Chen B, Zhu C. Zhang X, et al. Among authors: xu y. J Surg Oncol. 2015 Jun;111(7):834-9. doi: 10.1002/jso.23888. J Surg Oncol. 2015. PMID: 25919911

4

Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma.

Gu L, Xu Y, Chen Z, Pan Y, Lu S. Gu L, et al. Among authors: xu y. Biomed Pharmacother. 2015 Dec;76:134-40. doi: 10.1016/j.biopha.2015.10.009. Epub 2015 Nov 18. Biomed Pharmacother. 2015. PMID: 26653560

5

An open, observational, three-arm clinical study of 2-3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis.

Gu L, Wang X, Sun Y, Xu Y, Niu X, Zhao R, Yao Y, Jian H, Han Y, Wei J, Chen Z, Lu S. Gu L, et al. Among authors: xu y. Front Immunol. 2022 Aug 19;13:938269. doi: 10.3389/fimmu.2022.938269. eCollection 2022. Front Immunol. 2022. PMID: 36059450 Free PMC article.

6

Recombinant human thrombopoietin combined with interleukin-2 improves the effects of chemosensitivity and thrombocytopenia on a basic gemcitabine and carboplatin combination therapy for non-small cell lung cancer in a nude mouse model.

Xu Y, Pan Y, Zhou Z. Xu Y, et al. J Thorac Dis. 2019 Nov;11(11):4671-4681. doi: 10.21037/jtd.2019.10.58. J Thorac Dis. 2019. PMID: 31903256 Free PMC article.

7

Mini-patient-derived xenograft assay based on microfluidic technology promises to be an effective tool for screening individualized chemotherapy regimens for advanced non-small cell lung cancer.

Wang X, Sun Y, Xu Y, Wen D, An N, Leng X, Fu G, Lu S, Chen Z. Wang X, et al. Among authors: xu y. Cell Biol Int. 2021 Sep;45(9):1887-1896. doi: 10.1002/cbin.11622. Epub 2021 Jun 26. Cell Biol Int. 2021. PMID: 33945662

8

Efficacy and safety of a new disposable percutaneous positioning device invented to facilitate the precision of percutaneous core needle lung biopsies: a prospective, open and randomized controlled study.

Xu Y, Fu J, Cao W, Zhu L, Jin Y, Yin Q, Ye J, Zhou H. Xu Y, et al. J Thorac Dis. 2021 Aug;13(8):4965-4976. doi: 10.21037/jtd-20-3282. J Thorac Dis. 2021. PMID: 34527335 Free PMC article.

9

Regulation of β-catenin-mediated esophageal cancer growth and invasion by miR-214.

Xu Y, Lu S. Xu Y, et al. Am J Transl Res. 2015 Nov 15;7(11):2316-25. eCollection 2015. Am J Transl Res. 2015. PMID: 26807179 Free PMC article.

10

Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay.

Guo QM, Wang L, Yu WJ, Qiao LH, Zhao MN, Hu XM, Sun YM, Ni S, Xu YH, Lou JT. Guo QM, et al. J Cancer. 2019 Jul 10;10(18):4341-4349. doi: 10.7150/jca.31326. eCollection 2019. J Cancer. 2019. PMID: 31413754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,307 results

Search Page

Filters